metformin has been researched along with Gingival Hyperplasia in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Gingival Hyperplasia: Non-inflammatory enlargement of the gingivae produced by factors other than local irritation. It is characteristically due to an increase in the number of cells. (From Jablonski's Dictionary of Dentistry, 1992, p400)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Felodipine was withdrawn and the diabetes was controlled before dental treatment was initiated." | 1.33 | Felodipine-influenced gingival enlargement in an uncontrolled type 2 diabetic patient. ( Fay, AA; Gapski, R; Satheesh, K, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fay, AA | 1 |
| Satheesh, K | 1 |
| Gapski, R | 1 |
1 other study available for metformin and Gingival Hyperplasia
| Article | Year |
|---|---|
Felodipine-influenced gingival enlargement in an uncontrolled type 2 diabetic patient.
Topics: Alveolar Bone Loss; Anti-Bacterial Agents; Anticholesteremic Agents; Calcium Channel Blockers; Denta | 2005 |